Who owns INAB?
Institutional ownership of IN8bio Inc. from Form 13F, Q2 2026
21 institutional managers reported holding IN8bio Inc. (INAB) in Form 13F filings for Q2 2026, with 3,789,835 shares worth $5.3M. The largest reported holder was Alyeska Investment Group, L.P. Managers that filed both quarters added a net 37,041 shares (+1.0%). 3 opened new positions and 1 sold out.
- Funds holding
- 21
- Value held
- $5.3M
- New / sold out
- 3 / 1
- Net shares, same filers
- +1.0%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of INAB
Share of 13F holdings is each fund's shares as a share of the 3,789,835 INAB shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Citadel Advisors LLC New+$89K
- Oppenheimer & Co Inc Added+$55K
- Stonepine Capital Management, LLC Added+$45K
- Renaissance Technologies LLC New+$17K
- Tower Research Capital LLC (TRC) Added+$3K
- Northern Trust Corp Added+$2K
- Texas Capital Bank Wealth Management Services Inc Added+$925
- Barclays PLC New+$39
Biggest sellers in Q2 2026
- BIOS Capital Management, LP Trimmed-$122K
- Geode Capital Management, LLC Trimmed-$19K
- XTX Topco Ltd Sold out-$18K
- UBS Group AG Trimmed-$479
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $212K and sold $161K; 5 added and 3 trimmed.
Schedule 13D and 13G filings on INAB
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-03-02LYTTON LAURENCE W SCHEDULE 13G filed by IN8bio Inc.Schedule 13G
- 2026-02-17Alyeska Investment Group, L.P. SCHEDULE 13G filed by IN8bio Inc.Schedule 13G
- 2026-01-29FRANKLIN RESOURCES INC SCHEDULE 13G filed by IN8bio Inc.Schedule 13G
- 2026-01-03FAIRBAIRN EMILY SCHEDULE 13D filed by IN8bio Inc.Schedule 13D
- 2025-12-30683 Capital Management, LLC SCHEDULE 13G filed by IN8bio Inc.Schedule 13G
- 2025-12-22Stonepine Capital Management, LLC SCHEDULE 13G filed by IN8bio Inc.Schedule 13G
- 2025-02-14Alyeska Investment Group, L.P. SCHEDULE 13G filed by IN8bio Inc.Schedule 13G
Questions about INAB ownership
- Who owns INAB stock?
- 21 institutional investment managers reported INAB positions in their Form 13F filings for Q2 2026, holding 3,789,835 shares worth $5.3M in total. Alyeska Investment Group, L.P. reported the largest position.
- Are funds buying or selling INAB?
- In Q2 2026, 3 managers opened new INAB positions, 5 added, 3 trimmed and 1 sold out. Managers that filed in both quarters added a net 37,041 shares.
- How current is this INAB institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to INAB by CUSIP. Options are left out. INAB news and filings · INAB insider trades · Top funds